John Phair

29.8k total citations · 8 hit papers
353 papers, 22.0k citations indexed

About

John Phair is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, John Phair has authored 353 papers receiving a total of 22.0k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Infectious Diseases, 128 papers in Virology and 101 papers in Epidemiology. Recurrent topics in John Phair's work include HIV Research and Treatment (128 papers), HIV/AIDS Research and Interventions (91 papers) and HIV/AIDS drug development and treatment (80 papers). John Phair is often cited by papers focused on HIV Research and Treatment (128 papers), HIV/AIDS Research and Interventions (91 papers) and HIV/AIDS drug development and treatment (80 papers). John Phair collaborates with scholars based in United States, United Kingdom and Israel. John Phair's co-authors include Roger Detels, Charles R. Rinaldo, Richard A. Kaslow, Álvaro Muñoz, Alfred J. Saah, Joseph B. Margolick, B. Frank Polk, Steven M. Wolinsky, Lisa P. Jacobson and David G. Ostrow and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

John Phair

345 papers receiving 20.9k citations

Hit Papers

A Controlled Trial of Two Nucleoside Analogues plus Indin... 1987 2026 2000 2013 1997 1996 1987 2002 1996 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
    1997 2.1k citations John Phair et al. New England Journal of Medicine profile →
  2. The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
    1996 1.1k citations John Phair et al. Nature Medicine profile →
  3. THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTS
    1987 975 citations Richard A. Kaslow, David G. Ostrow et al. profile →
  4. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
    2002 837 citations Chloe L. Thio, Eric C. Seaberg et al. The Lancet profile →
  5. A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
    1996 768 citations David Katzenstein, John Phair et al. New England Journal of Medicine profile →
  6. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
    1996 636 citations Shou‐Jiang Gao, Lawrence Kingsley et al. Nature Medicine profile →
  7. The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1
    1990 530 citations John Phair, Álvaro Muñoz et al. New England Journal of Medicine profile →
  8. Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy
    1999 514 citations John Phair et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Phair United States 69 11.0k 9.5k 7.6k 4.0k 3.0k 353 22.0k
Brian Gazzard United Kingdom 77 12.2k 1.1× 8.9k 0.9× 7.0k 0.9× 2.4k 0.6× 3.3k 1.1× 494 21.8k
Adriano Lazzarin Italy 70 12.2k 1.1× 10.9k 1.1× 6.2k 0.8× 2.8k 0.7× 3.4k 1.1× 616 20.6k
Martin Hirsch United States 72 13.6k 1.2× 13.0k 1.4× 7.2k 0.9× 3.8k 0.9× 2.4k 0.8× 274 24.1k
Margaret A. Fischl United States 62 16.5k 1.5× 12.5k 1.3× 6.8k 0.9× 2.0k 0.5× 3.4k 1.1× 268 23.5k
Charles R. Rinaldo United States 66 8.0k 0.7× 9.4k 1.0× 7.2k 0.9× 6.6k 1.6× 1.4k 0.5× 347 19.6k
Henry Masur United States 88 10.4k 0.9× 6.1k 0.6× 17.4k 2.3× 5.1k 1.3× 2.6k 0.9× 375 33.5k
Joseph B. Margolick United States 64 10.2k 0.9× 12.9k 1.4× 4.1k 0.5× 4.8k 1.2× 3.7k 1.2× 257 19.7k
Dominique Costagliola France 69 9.0k 0.8× 7.3k 0.8× 5.6k 0.7× 1.9k 0.5× 3.9k 1.3× 450 17.8k
Michael M. Lederman United States 78 9.8k 0.9× 13.1k 1.4× 6.4k 0.8× 8.4k 2.1× 5.0k 1.7× 381 24.7k
Jeffrey N. Martin United States 79 11.7k 1.1× 11.6k 1.2× 6.7k 0.9× 5.7k 1.4× 5.3k 1.7× 340 23.5k

Countries citing papers authored by John Phair

Since Specialization
Citations

This map shows the geographic impact of John Phair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Phair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Phair more than expected).

Fields of papers citing papers by John Phair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Phair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Phair. The network helps show where John Phair may publish in the future.

Co-authorship network of co-authors of John Phair

This figure shows the co-authorship network connecting the top 25 collaborators of John Phair. A scholar is included among the top collaborators of John Phair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Phair. John Phair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carnevale, Matthew, et al.. (2022). Acute Kidney Injury Risk and Contrast Volume in Intact Versus Ruptured Endovascular Aneurysm Repair in the Vascular Quality Initiative. Vascular and Endovascular Surgery. 56(6). 581–589. 3 indexed citations
2.
Phair, John, Matthew Carnevale, Evan C. Lipsitz, et al.. (2020). Underutilization of Nonopioid Pain Medication in Patients Undergoing Abdominal Aortic Aneurysm Repair. Annals of Vascular Surgery. 68. 292–298. 5 indexed citations
3.
Price, Jennifer C., Eric C. Seaberg, John Phair, et al.. (2016). Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 72(3). 319–323. 4 indexed citations
4.
Li, Xiuhong, Wendy S. Post, Lisa P. Jacobson, et al.. (2016). Associations between antiretroviral use and subclinical coronary atherosclerosis. AIDS. 30(16). 2477–2486. 13 indexed citations
5.
Abraham, Alison G., Xiuhong Li, Lisa P. Jacobson, et al.. (2013). Antiretroviral Therapy-Induced Changes in Plasma Lipids and the Risk of Kidney Dysfunction in HIV-Infected Men. AIDS Research and Human Retroviruses. 29(10). 1346–1352. 6 indexed citations
6.
Mata, Mariana M., Beth D. Jamieson, John Phair, et al.. (2013). Comparison of Antibodies That Mediate HIV Type 1 gp120 Antibody-Dependent Cell-Mediated Cytotoxicity in Asymptomatic HIV Type 1-Positive Men and Women. AIDS Research and Human Retroviruses. 30(1). 50–57. 3 indexed citations
7.
Williams, Carolyn, Donna Klinzman, Traci E. Yamashita, et al.. (2004). Persistent GB Virus C Infection and Survival in HIV-Infected Men. New England Journal of Medicine. 350(10). 981–990. 196 indexed citations
8.
Winkler, Cheryl A., Houria Hendel, Mary Carrington, et al.. (2004). Dominant Effects of CCR2-CCR5 Haplotypes in HIV-1 Disease Progression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(4). 1534–1538. 25 indexed citations
9.
Thio, Chloe L., Eric C. Seaberg, Richard L. Skolasky, et al.. (2002). HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). The Lancet. 360(9349). 1921–1926. 837 indexed citations breakdown →
10.
An, Ping, George W. Nelson, Lihua Wang, et al.. (2002). Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proceedings of the National Academy of Sciences. 99(15). 10002–10007. 153 indexed citations
11.
Landay, Alan, Ellen S. Chan, John Spritzler, et al.. (2002). Evidence of Immune Reconstitution in Antiretroviral Drug-Experienced Patients with Advanced HIV Disease. AIDS Research and Human Retroviruses. 18(2). 95–102. 29 indexed citations
12.
Wanke, Christine, Julian Falutz, Abby Shevitz, John Phair, & Donald P. Kotler. (2002). Clinical Evaluation and Management of Metabolic and Morphologic Abnormalities Associated with Human Immunodeficiency Virus. Clinical Infectious Diseases. 34(2). 248–259. 44 indexed citations
13.
Chien, Peter, Sandra Cohen, Cynthia A. Kleeberger, et al.. (2002). High Levels of Antibodies to the CD4 Binding Domain of Human Immunodeficiency Virus Type 1 Glycoprotein 120 Are Associated with Faster Disease Progression. The Journal of Infectious Diseases. 186(2). 205–213. 13 indexed citations
14.
Gange, Stephen J., John W. Mellors, Bryan Lau, et al.. (2001). Longitudinal Patterns of HIV Type 1 RNA among Individuals with Late Disease Progression. AIDS Research and Human Retroviruses. 17(13). 1223–1229. 13 indexed citations
15.
Gao, Shou‐Jiang, Lawrence Kingsley, Ming O. Li, et al.. (1996). KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Medicine. 2(8). 925–928. 636 indexed citations breakdown →
16.
Phair, John. (1994). Variations in the Natural History of HIV Infection. AIDS Research and Human Retroviruses. 10(8). 883–885. 20 indexed citations
17.
Clerici, Mario, Alan Landay, Harold A. Kessler, et al.. (1992). Reconstitution of Long-Term T Helper Cell Function after Zidovudine Therapy in Human Immunodeficiency Virus-Infected Patients. The Journal of Infectious Diseases. 166(4). 723–730. 30 indexed citations
18.
Sarov, Batia, I Sarov, Charles R. Rinaldo, et al.. (1990). Serum IgG and IgA Antibodies Specific to Epstein-Barr Virus Capsid Antigen in a Longitudinal Study of Human Immunodeficiency Virus Infection and Disease Progression in Homosexual Men. AIDS Research and Human Retroviruses. 6(5). 607–616. 19 indexed citations
19.
Sawyer, Leigh A., David Katzenstein, R. Michael Hendry, et al.. (1990). Possible Beneficial Effects of Neutralizing Antibodies and Antibody-Dependent, Cell-Mediated Cytotoxicity in Human Immunodeficiency Virus Infection. AIDS Research and Human Retroviruses. 6(3). 341–356. 66 indexed citations
20.
McArthur, Justin C., Bruce A. Cohen, David R. Cornblath, et al.. (1988). Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Annals of Neurology. 23(S1). S34–S37. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Gazzard Breakdown of academic impact, for papers by Adriano Lazzarin Breakdown of academic impact, for papers by Martin Hirsch Breakdown of academic impact, for papers by Margaret A. Fischl Breakdown of academic impact, for papers by Charles R. Rinaldo Breakdown of academic impact, for papers by Henry Masur Breakdown of academic impact, for papers by Joseph B. Margolick Breakdown of academic impact, for papers by Dominique Costagliola Breakdown of academic impact, for papers by Michael M. Lederman Breakdown of academic impact, for papers by Jeffrey N. Martin
Rankless by CCL
2026